Long-term management of canine disseminated granulomatous meningoencephalitis with imatinib mesylate: a case report

被引:1
作者
Song, Joong Hyun [1 ]
Hwang, Tae Sung [1 ]
Lee, Hee Chun [1 ]
Yu, Do Hyeon [1 ]
Seung, Byung Joon [2 ]
Sur, Jung Hyang [2 ]
Jung, Dong In [1 ]
机构
[1] Gyeongsang Natl Univ, Coll Vet Med, Inst Anim Med, Jinju, South Korea
[2] Konkuk Univ, Coll Vet Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
dog; immunohistochemical staining; magnetic resonance imaging; unknown aetiology; tyrosine kinase; tyrosine kinase inhibitor; NECROTIZING MENINGOENCEPHALITIS; HYDROXYUREA; DOGS; MODELS;
D O I
10.17221/70/2018-VETMED
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
A seven-year-old Toy Poodle was presented for progressive ataxia and seizure episodes. Magnetic resonance imaging revealed inflammatory lesions in the cerebrum and brainstem. Management with imatinib mesylate, prednisolone and hydroxyurea were initiated and resulted in complete resolution of the clinical signs. In regular magnetic resonance imaging scans, the overall appearance of the lesions deteriorated but improved again after an increase in the imatinib mesylate dose. The patient had not shown any neurological signs until death and survived for 1052 days after initial presentation. On histopathological examination, the patient was diagnosed with disseminated granulomatous meningoencephalitis involving the cerebrum and brainstem. Immunohistochemical staining was performed on the five types of tyrosine kinase (PDGFR-alpha, PDGFR-beta, VEGFR-2, c-Kit and c-Abl proteins), which constitute therapeutic targets for conventional multitargeted tyrosine kinase inhibitors. The immunohistochemical analysis revealed that all these tyrosine kinases were expressed in the brain samples. The present report describes the first case of the use of imatinib mesylate therapy for granulomatous meningoencephalitis in the dog. Therapy with imatinib mesylate plus glucocorticoids appears promising as a new therapeutic intervention in meningoencephalitis of unknown aetiology.
引用
收藏
页码:92 / 99
页数:8
相关论文
共 25 条
[1]   Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis [J].
Akashi, Naotsugu ;
Matsumoto, Isao ;
Tanaka, Yoko ;
Inoue, Asuka ;
Yamamoto, Kayo ;
Umeda, Naoto ;
Tanaka, Yuki ;
Hayashi, Taichi ;
Goto, Daisuke ;
Ito, Satoshi ;
Sekiguchi, Kaneo ;
Sumida, Takayuki .
MODERN RHEUMATOLOGY, 2011, 21 (03) :267-275
[2]  
Azizi G, 2014, IRAN J ALLERGY ASTHM, V13, P198
[3]   Imatinib Mesylate: An Innovation in Treatment of Autoimmune Diseases [J].
Azizi, Gholamreza ;
Mirshafiey, Abbas .
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2013, 7 (03) :259-267
[4]   Dysregulation of tyrosine kinases and use of imatinib in small animal practice [J].
Bonkobara, Makoto .
VETERINARY JOURNAL, 2015, 205 (02) :180-188
[5]  
BRAUND KG, 1985, J AM VET MED ASSOC, V186, P138
[6]  
Coates JR, 2007, ADV SMALL ANIMAL MED, V20, P1
[7]   Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis [J].
Coffey, Greg ;
DeGuzman, Francis ;
Inagaki, Mayuko ;
Pak, Yvonne ;
Delaney, Suzanne M. ;
Ives, Dan ;
Betz, Andreas ;
Jia, Zhaozhong J. ;
Pandey, Anjali ;
Baker, Dale ;
Hollenbach, Stanley J. ;
Phillips, David R. ;
Sinha, Uma .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (02) :350-359
[8]   Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases [J].
Eklund, KK ;
Joensuu, H .
ANNALS OF MEDICINE, 2003, 35 (05) :362-367
[9]  
Fisher M, 2002, CAN VET J, V43, P49
[10]   Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: A systematic review of 457 published cases from 1962 to 2008 [J].
Granger, Nicolas ;
Smith, Peter M. ;
Jeffery, Nick D. .
VETERINARY JOURNAL, 2010, 184 (03) :290-297